Skip to main content
Erschienen in: Osteoporosis International 12/2003

01.12.2003 | Original Article

Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis

verfasst von: Barbara M Obermayer-Pietsch, Uwe Lange, Gerlinde Tauber, Gerwig Frühauf, Astrid Fahrleitner, Harald Dobnig, Josef Hermann, Ferdinand Aglas, Joachim Teichmann, Gunter Neeck, Georg Leb

Erschienen in: Osteoporosis International | Ausgabe 12/2003

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Osteoporosis is a common finding in ankylosing spondylitis (AS) and may contribute to spinal deformity and bone pain. Bone metabolism as well as inflammatory processes are influenced by the vitamin D receptor gene (VDR). We investigated initiation codon (FokI) and 3’UTR (BsmI) polymorphisms of the VDR for whether there could be an association with bone mineral density (BMD) in relation to bone metabolism or inflammatory activity in patients with AS.

Methods

In this study, 104 patients with AS (m/w 71/33, mean age 41±12 years) were investigated for their lumbar and femoral BMD by DEXA and in part by QCT measurements and compared to 54 healthy controls. Disease activity indices, serum markers of bone metabolism and inflammation were recorded. FokI and BsmI polymorphisms of the VDR were genotyped using genomic DNA from peripheral leukocytes with present or absent restriction sites defined as alleles “f” and “b” or “F” and “B,” respectively.

Results

In male AS patients, FokI genotypes were significantly associated with spinal but not with femoral BMD values (P=0.01) as independent predictors of low BMD, which was also influenced by BMI, and inflammatory and pain indices. CRP and ESR values were also significantly associated with FokI genotypes. BMD in female patients showed no significant association with either FokI or BsmI genotypes of the VDR.

Conclusion

This is the first evidence that the VDR gene may be involved in BMD differences, bone metabolism and inflammatory processes in ankylosing spondylitis. A possible interaction of the vitamin D system, cytokines and bone could define new diagnostic and therapeutic implications in ankylosing spondylitis.
Literatur
1.
Zurück zum Zitat Will R, Palmer R, Bhalla AK, et al (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485PubMed Will R, Palmer R, Bhalla AK, et al (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485PubMed
2.
Zurück zum Zitat Ralston SH, Urquhart GD, Brzeski M, et al (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300:563–565PubMed Ralston SH, Urquhart GD, Brzeski M, et al (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300:563–565PubMed
3.
Zurück zum Zitat Sivri A, Kilinc S, Gokce-Kutsal Y, et al (1996) Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15:51–54PubMed Sivri A, Kilinc S, Gokce-Kutsal Y, et al (1996) Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15:51–54PubMed
4.
Zurück zum Zitat El Maghraoui A, Borderie D, Cherruau B, et al (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209PubMed El Maghraoui A, Borderie D, Cherruau B, et al (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209PubMed
5.
Zurück zum Zitat Donnelly S, Doyle DV, Denton A, et al (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMed Donnelly S, Doyle DV, Denton A, et al (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMed
6.
Zurück zum Zitat Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368CrossRefPubMed Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368CrossRefPubMed
7.
Zurück zum Zitat Kanis JA, Melton III LJ, Christiansen C, et al (1994) The diagnosis of osteoporosis. J Bone Min Res 9:1137–1141 Kanis JA, Melton III LJ, Christiansen C, et al (1994) The diagnosis of osteoporosis. J Bone Min Res 9:1137–1141
8.
Zurück zum Zitat Toussirot E, Nguyen NU, Dumoulin G, et al (1998) Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol 37:1172–1176CrossRefPubMed Toussirot E, Nguyen NU, Dumoulin G, et al (1998) Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol 37:1172–1176CrossRefPubMed
9.
Zurück zum Zitat Bronson WD, Walker SE, Hillman LS, et al (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25:929–935PubMed Bronson WD, Walker SE, Hillman LS, et al (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25:929–935PubMed
10.
Zurück zum Zitat Lange U, Jung O, Teichmann J, et al (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031–1035CrossRefPubMed Lange U, Jung O, Teichmann J, et al (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031–1035CrossRefPubMed
11.
Zurück zum Zitat Obermayer-Pietsch BM, Fruhauf GE, Chararas K, et al (2000) Association of the vitamin D receptor genotype BB with low bone density in hyperthyroidism. J Bone Min Res 15:1950–1955 Obermayer-Pietsch BM, Fruhauf GE, Chararas K, et al (2000) Association of the vitamin D receptor genotype BB with low bone density in hyperthyroidism. J Bone Min Res 15:1950–1955
12.
Zurück zum Zitat Gross C, Eccleshall TR, Malloy PJ, et al (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American woman. J Bone Min Res 11:1850–1855 Gross C, Eccleshall TR, Malloy PJ, et al (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American woman. J Bone Min Res 11:1850–1855
13.
Zurück zum Zitat Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79–94PubMed Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79–94PubMed
14.
Zurück zum Zitat Ferrari S, Rizzoli R, Manen D, et al (1998) Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3’-end region polymorphisms. J Bone Min Res 13:925–930 Ferrari S, Rizzoli R, Manen D, et al (1998) Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3’-end region polymorphisms. J Bone Min Res 13:925–930
15.
Zurück zum Zitat Harris S, Ross Eccleshall T, et al (1997) The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white woman. J Bone Min Res 12:1043–1048 Harris S, Ross Eccleshall T, et al (1997) The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white woman. J Bone Min Res 12:1043–1048
16.
Zurück zum Zitat Lau EM, Lam V, Li M, et al (2002) Vitamin D receptor start codon polymorphism (FokI) and bone mineral density in Chinese men and women. Osteoporos Int 13:218–221CrossRef Lau EM, Lam V, Li M, et al (2002) Vitamin D receptor start codon polymorphism (FokI) and bone mineral density in Chinese men and women. Osteoporos Int 13:218–221CrossRef
17.
Zurück zum Zitat Moll JM, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32:354–363PubMed Moll JM, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32:354–363PubMed
18.
Zurück zum Zitat Goie The HS, Steven MM, van der Linden SM, et al (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24:242–249 Goie The HS, Steven MM, van der Linden SM, et al (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24:242–249
19.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2289–2291 Garrett S, Jenkinson T, Kennedy LG, et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2289–2291
20.
Zurück zum Zitat Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099–1106PubMed Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099–1106PubMed
21.
Zurück zum Zitat Spittler A, Willheim M, Leumetzer F, et al (1997) Effects of 1 alpha, 25-dihydroxyvitamin D-3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis. Immunology 90:286–293PubMed Spittler A, Willheim M, Leumetzer F, et al (1997) Effects of 1 alpha, 25-dihydroxyvitamin D-3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis. Immunology 90:286–293PubMed
22.
Zurück zum Zitat D’Ambrosio P, Cippitelli M, Cocciolo MG, et al (1998) Inhibition of IL12 production by 1α,25(OH)2D3—involvement of NF-kappa B downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252–262PubMed D’Ambrosio P, Cippitelli M, Cocciolo MG, et al (1998) Inhibition of IL12 production by 1α,25(OH)2D3—involvement of NF-kappa B downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252–262PubMed
23.
Zurück zum Zitat Larsson P, Mattsson L, Klareskog L, et al (1998) A vitamin D analogue ( MC1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114:277–283CrossRefPubMed Larsson P, Mattsson L, Klareskog L, et al (1998) A vitamin D analogue ( MC1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114:277–283CrossRefPubMed
24.
Zurück zum Zitat Vogel A, Strassburg CP, Manns MP (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35):126–131CrossRefPubMed Vogel A, Strassburg CP, Manns MP (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35):126–131CrossRefPubMed
25.
Zurück zum Zitat Simmons JD, Mullighan C, Welsh KI, et al (2000) Vitamin D receptor gene polymorphism: association with Crohn’s disease susceptibility. Gut 47:211–214CrossRefPubMed Simmons JD, Mullighan C, Welsh KI, et al (2000) Vitamin D receptor gene polymorphism: association with Crohn’s disease susceptibility. Gut 47:211–214CrossRefPubMed
26.
Zurück zum Zitat Ban Y, Taniyama M, Yanagawa T, et al (2001) Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet 2:7PubMed Ban Y, Taniyama M, Yanagawa T, et al (2001) Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet 2:7PubMed
27.
Zurück zum Zitat Lange U (2000) Skeletal status in ankylosing spondylitis. J Rheumatol 27:4.27 Lange U (2000) Skeletal status in ankylosing spondylitis. J Rheumatol 27:4.27
29.
Zurück zum Zitat Overbergh L, Decallonne B, Valckx D, et al (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120:139–146CrossRefPubMed Overbergh L, Decallonne B, Valckx D, et al (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120:139–146CrossRefPubMed
30.
Zurück zum Zitat Oelzner P, Müller A, Deschner F, et al (1998) Relationsship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tiss Int 62:193–198CrossRef Oelzner P, Müller A, Deschner F, et al (1998) Relationsship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tiss Int 62:193–198CrossRef
31.
Zurück zum Zitat Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507–511PubMed Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507–511PubMed
32.
Zurück zum Zitat Baeten D, Kruithof E, Van den Bosch F, et al (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 44:186–195CrossRefPubMed Baeten D, Kruithof E, Van den Bosch F, et al (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 44:186–195CrossRefPubMed
33.
Zurück zum Zitat Quinn JM, Itoh K, Udagawa N (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Min Res 16:1787–1794 Quinn JM, Itoh K, Udagawa N (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Min Res 16:1787–1794
34.
Zurück zum Zitat Fernandez-Martin JL, Kurian S, Farmer P et al (1998) Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Mol Cell Endocrinol 25:65–72CrossRef Fernandez-Martin JL, Kurian S, Farmer P et al (1998) Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Mol Cell Endocrinol 25:65–72CrossRef
35.
Zurück zum Zitat Kuno H, Kurian SM, Hendy GN, et al (1994) Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 134:2524–2531PubMed Kuno H, Kurian SM, Hendy GN, et al (1994) Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 134:2524–2531PubMed
36.
Zurück zum Zitat Schacht E (2000) Osteoporosis in rheumatoid arthritis: significance of alfacalcidol in prevention and therapy. Z Rheumatol 59:10–20CrossRefPubMed Schacht E (2000) Osteoporosis in rheumatoid arthritis: significance of alfacalcidol in prevention and therapy. Z Rheumatol 59:10–20CrossRefPubMed
37.
Zurück zum Zitat Shany S, Levy Y, Lahav-Cohen M (2001) The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 66:319–325CrossRefPubMed Shany S, Levy Y, Lahav-Cohen M (2001) The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 66:319–325CrossRefPubMed
38.
Zurück zum Zitat Shiraishi A, Takeda S, Masaki T et al (2000) Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Min Res 15:770–779 Shiraishi A, Takeda S, Masaki T et al (2000) Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Min Res 15:770–779
Metadaten
Titel
Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis
verfasst von
Barbara M Obermayer-Pietsch
Uwe Lange
Gerlinde Tauber
Gerwig Frühauf
Astrid Fahrleitner
Harald Dobnig
Josef Hermann
Ferdinand Aglas
Joachim Teichmann
Gunter Neeck
Georg Leb
Publikationsdatum
01.12.2003
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 12/2003
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-003-1501-5

Weitere Artikel der Ausgabe 12/2003

Osteoporosis International 12/2003 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.